Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Subpotent Drug: FDA analysis found product to be subpotent
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Failed Dissolution Specifications
Sub-Potent Drug: Out of specification test results for potency (below specification).
CGMP Deviations
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.
Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.